Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BLOOMFIELD, Conn., Nov. 4, 2021 /PRNewswire/ -- Total revenues in the third quarter were $44.3 billion, and adjusted revenues1 were $44.3 billion Shareholders' net income for the third quarter was $1.6 billion, or $4.80 per share Adjusted income from operations2 for the third quarter was $1.9 billion, or $5.73 per share Adjusted income from operations2,3 for 2021 is now projected to be at least $20.35 per share Global health services company Cigna Corporation (NYSE: CI) today reported third quarter 2021 results with strong revenue and earnings growth across its businesses.

Cigna Reports Third Quarter 2021 Results, Raises 2021 Outlook

Cigna Corp. CI, +1.65% said Thursday it had net income of $1.621 billion, or $4.80 a share, in the third quarter, up from $1.388 billion, or $3.78 a share, in the year-earlier period. Adjusted per-share earnings came to $5.73, ahead of the FactSet consensus of $5.23.

Cigna tops estimates for third quarter and raises EPS guidance

Cigna's (CI) Q3 results are likely to reflect growth in earnings and revenues.

Cigna (CI) to Post Earnings in Q3: What's in the Offing?

Cigna has been paying a token dividend of 4 cents annually. Last March, the company has shifted to a quarterly meaningful dividend. We are approaching the company's expected dividend increase, and it's time to consider the company for dividend growth portfolios.

Cigna Is Going To Raise The Dividend, And It's Time For You To Consider

Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cigna (CI) Earnings Expected to Grow: Should You Buy?

BLOOMFIELD, Conn., Oct. 28, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present at the Wolfe Research Virtual Healthcare Conference on November 18, 2021 through a virtual webcast.

Cigna Corporation Announces Appearance at the Wolfe Research Virtual Healthcare Conference

BLOOMFIELD, Conn., Oct. 26, 2021 /PRNewswire/ -- Cigna Health Plan today announced it is significantly expanding access to covered virtual care services for millions of customers.

Cigna Makes On-Demand Virtual Care Easier and More Convenient Through Expanded MDLIVE Services

Banner

Redwood Trust

Valero Energy

Kite Realty Group

All the brokerage firms and banks that we follow here at 24/7 Wall St. keep a list for their institutional and retail clients of high-conviction stock picks.

5 Top Analyst Favorite Stock Picks to Buy Come With Big Dividends

Bristol-Myers

Stock bargains can exist in both bull and bear markets alike. I present 2 blue-chips with moat-worthy businesses that are trading rather cheaply at the moment.

2 Buffett-Style Fat Pitches You Won't Want To Miss

1Life Healthcare

NASHVILLE, Tenn., Oct. 20, 2021 /PRNewswire/ -- Cigna Corporation, a global health service company, has added Iora Primary Care providers to its Medicare Advantage (MA) network in Arizona's Maricopa County, which includes Phoenix.

Cigna Adds Iora Primary Care to Medicare Advantage Network in Phoenix Area

Shares of healthcare providers and insurers, including Cigna Corp (NYSE: CI) are trading higher in sympathy with Anthem, which gained after reporting better-than-expected third-quarter results and raising FY21 guidance. Anthem reported quarterly earnings of $6.79 per share which beat the analyst consensus estimate of $6.39 by 6.3%.

Why Cigna Corporation Shares Are Rising

Viatris

Cigna Corp's pharmacy benefit unit said on Wednesday it will prefer Viatris Inc and Biocon Biologics Ltd's insulin drug Semglee, a cheaper alternative to Sanofi SA's Lantus, on the list of medicines it reimburses on behalf of health insurers.

Cigna's pharmacy benefit unit to prefer cheaper insulin drug from Viatris

BLOOMFIELD, Conn., Oct. 19, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present at the Credit Suisse 30th Annual Healthcare Conference on November 9, 2021 through a virtual webcast.

Cigna Corporation Announces Appearance at the Credit Suisse 30th Annual Healthcare Conference

Aflac

Arthur J. Gallagher & Co.

Athene Holding Ltd. Class A

MetLife

Primerica

W. R. Berkley

Better pricing, exposure growth, redesigning of products and sturdy capital are expected to help WRB, ATH, MET, PRI, CI, AJG, and AFL outperform Q3 earnings estimates.

7 Insurers Poised to Outperform Q3 Earnings Expectation

PORTLAND, Ore., Oct. 19, 2021 /PRNewswire/ -- Cigna is expanding its Medicare business to Portland, offering Medicare Advantage (MA) plans in several counties there and giving local Medicare beneficiaries more choices, including plan benefits not offered by Original Medicare, such as vision, dental, and hearing coverage.

Cigna Offering Medicare Advantage in the Portland Area

D.R. Horton

FedEx

Progressive

Regeneron Pharmaceuticals

We believe that FedEx Corporation stock, Regeneron Pharmaceuticals stock, D.R. Horton Stock, Progressive Corp Stock, and Cigna Corp Stock are currently better valued than Best Buy stock.

These Stocks Are Better Buying Opportunities Compared To Best Buy

BLOOMFIELD, Conn., Oct. 14, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) will release its third quarter 2021 financial results on Thursday, November 4, 2021, and will host a conference call the same day.

Cigna Corporation's Third Quarter 2021 Earnings Release Details

Cigna has seen material share price weakness in recent months, and trades in what I see as being deep-value territory. I see market concerns around the business as being overblown, and management targets robust free cash flow generation.

Cigna: Now The Perfect Stock To Build A Retirement Portfolio Around

Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why the Earnings Surprise Streak Could Continue for Cigna (CI)

Amgen

Activision Blizzard

Alibaba

BHP Billiton

Biogen

Cardinal Health

Clorox

Corning

Global Payments

Intel

Micron Technology

Newmont Mining

NetEase

Nucor

QUALCOMM

Rio Tinto plc Sponsored

Seagate Technology Holdings PLC

Skyworks Solutions

Taiwan Semiconductor Manufacturing

V.F.

Vertex Pharmaceuticals

Buying The Dip: 27 High Quality Stocks Trading At A 20%+ Discount

SINGAPORE--(BUSINESS WIRE)-- #insurance--AM Best has placed under review with positive implications the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of Cigna Life Insurance New Zealand Limited (CLINZ) (New Zealand). These Credit Rating (rating) actions follow the announcement on 7 October 2021, that Cigna Corporation [NYSE:CI], CLINZ's ultimate parent, has entered into a definitive agreement to sell its life, accident and supplemental benefits business

AM Best Places Credit Ratings of Cigna Life Insurance New Zealand Limited Under Review With Positive Implications

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb” (Good) and the Long- and Short-Term Issue Ratings of Cigna Corporation (Cigna) (Headquartered in Bloomfield, CT) [NYSE: CI] remain unchanged following Cigna's recent announcement that it has signed a definitive agreement to sell its life, accident and supplemental benefits business in seven countries to Chubb Limited. Additionally, the Financial Strength Ratings and Long-Term I

AM Best Comments on Credit Ratings of Cigna Corporation Following Asia-Pacific Business Sale Announcement

PayPal

Investing in these stocks could be a safe way to gain exposure to the growth of blockchain technology.

2 Growth Stocks Crypto Fans Would Love

Chubb

Cigna (CI) sells its businesses to Chubb to focus on core growth areas.

Cigna (CI) Divests Unit to Chubb to Streamline Business

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Credit Ratings (ratings) of Chubb Limited (Chubb) [NYSE: CB] and its insurance subsidiaries remain unchanged following the company's announcement of a definitive agreement to acquire the life and non-life insurance companies that house the personal accident, supplemental health and life insurance business of Cigna Corporation (NYSE: CI) in seven Asia-Pacific markets for $5.75 billion dollars in cash. (For a listing of Chubb's rating

News for Cigna Stock (CI)